Pdt Partners, LLC Sarepta Therapeutics, Inc. Transaction History

Pdt Partners, LLC

$1 Billion
Q4 2024

A detailed history of Pdt Partners, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 15,748 shares of SRPT stock, worth $1.71 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

15,748

Previous 39,024 59.65%

Holding current value

$1.71 Million

Previous $4.87 Million 60.73%

% of portfolio

0.19%

Previous 0.48%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$104.54 - $137.94 $2.43 Million - $3.21 Million	-23,276 Reduced 59.65%	15,748 $1.91 Million
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $471,832 - $594,866	3,795 Added 10.77%	39,024 $4.87 Million
Q2 2024 Aug 15, 2024	BUY	$113.33 - $163.85 $453 - $655	4 Added 0.01%	35,229 $5.57 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $2.37 Million - $4.39 Million	35,225 New	35,225 $3.4 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $1.05 Million - $1.39 Million	8,900 New	8,900 $1.23 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $1.36 Million - $2.15 Million	-18,012 Reduced 54.55%	15,006 $1.66 Million
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $2.63 Million - $3.71 Million	-41,977 Reduced 55.97%	33,018 $2.48 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $1.04 Million - $1.49 Million	16,528 Added 28.27%	74,995 $5.86 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $689,646 - $887,224	8,924 Added 18.01%	58,467 $5.27 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $857 - $1,202	-13 Reduced 0.03%	49,543 $4.58 Million
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $1.58 Million - $1.97 Million	22,756 Added 84.91%	49,556 $3.85 Million
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $1.94 Million - $4.53 Million	26,800 New	26,800 $2 Million
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $12.1 Million - $17.2 Million	-113,400 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $11.4 Million - $17.4 Million	-117,200 Reduced 50.82%	113,400 $12.4 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $2.52 Million - $3.53 Million	-21,879 Reduced 8.67%	230,600 $37.2 Million
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $11.7 Million - $25.1 Million	-163,109 Reduced 39.25%	252,479 $33.4 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $8.1 Million - $12.3 Million	-149,965 Reduced 26.52%	415,588 $30.8 Million
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $26.9 Million - $32.1 Million	565,553	565,553 $31.5 Million

Others Institutions Holding SRPT

# of Institutions

536

Shares Held

87.4M

Call Options Held

1.55M

Put Options Held

1.35M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.49B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account